Quince Therapeutics

Yahoo Finance • 25 days ago

Quince Therapeutics price target raised to $5 from $4 at D. Boral Capital

D. Boral Capital analyst Jason Kolbert raised the firm’s price target on Quince Therapeutics (QNCX) to $5 from $4 and keeps a Buy rating on the shares after the company said the last patient has completed their last visit in the pivotal Ph... Full story

Yahoo Finance • 3 months ago

J&J Snack Foods Enters Oversold Territory

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals a... Full story

Mentioned:

JJSF
WFC

Yahoo Finance • 6 months ago